XML 55 R21.htm IDEA: XBRL DOCUMENT v3.19.3
Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2019
Equity [Abstract]  
Summary of Option Activity under 2018 Plan, 2013 Plan and 2010 Plan

A summary of option activity under the 2018 Plan, 2013 Plan, and 2010 Plan for the nine months ended September 30, 2019, is as follows:

 

Year-to-Date Activity

 

Number

of Shares

 

 

Weighted

Average

Exercise

Price

 

 

Weighted

Average

Remaining

Contractual

Term (Years)

 

 

Aggregate

Intrinsic

Value

(in millions)

 

Options outstanding at December 31, 2018

 

 

781,725

 

 

$

16.34

 

 

 

9.0

 

 

 

 

 

Granted

 

 

1,063,150

 

 

 

13.84

 

 

 

 

 

 

 

 

 

Exercised

 

 

(7,813

)

 

 

11.81

 

 

 

 

 

 

 

 

 

Cancelled/forfeited

 

 

(451,398

)

 

 

22.95

 

 

 

 

 

 

 

 

 

Options outstanding at September 30, 2019

 

 

1,385,664

 

 

 

12.12

 

 

 

8.9

 

 

$

0.1

 

Options exercisable at September 30, 2019

 

 

328,707

 

 

$

11.34

 

 

 

7.2

 

 

$

0.1

 

Summary of Restricted Stock Unit Activity under 2018 Plan

 

A summary of restricted stock unit activity under the 2018 Plan for the nine months ended September 30, 2019, is as follows:

 

Year-to-Date Activity

 

Number

of Shares

 

 

Weighted

Average

Grant Date Fair Value Per Share

 

 

Aggregate

Intrinsic

Value

(in millions)

 

Non-vested outstanding at December 31, 2018

 

 

 

 

 

 

 

 

 

 

Granted

 

 

15,000

 

 

$

23.60

 

 

 

 

 

Cancelled/forfeited

 

 

(6,000

)

 

 

 

 

 

 

 

 

Non-vested outstanding at September 30, 2019

 

 

9,000

 

 

$

23.60

 

 

$

0.0

 

Summary of Stock-Based Compensation Expense The amount of stock-based compensation expense recorded to research and development expenses and to general and administrative expenses is detailed in table below:

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2019

 

 

2018

 

 

2019

 

 

2018

 

Stock-based compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

$

166,289

 

 

$

179,930

 

 

$

785,423

 

 

$

515,584

 

General and administrative

 

 

397,735

 

 

 

172,786

 

 

 

1,165,894

 

 

 

415,933

 

 

 

$

564,024

 

 

$

352,716

 

 

$

1,951,317

 

 

$

931,517